Literature DB >> 32036721

Resveratrol Combined with 17β-Estradiol Prevents IL-1β Induced Apoptosis in Human Nucleus Pulposus Via The PI3K/AKT/Mtor and PI3K/AKT/GSK-3β Pathway.

Xiaoliang Bai1, Xiaohui Guo1, Feng Zhang2, Long Zheng3, Wenyuan Ding1, Sidong Yang1.   

Abstract

BACKGROUNDS: Nucleus pulposus (NP) apoptosis is mainly charged for the pathological process of Intervertebral disc degeneration (IVDD). Our previous study revealed that Resveratrol (RSV) combined with 17β-estradiol (E2) was more effective in cutting down IL-1β induced NP cell apoptosis via PI3K/AKT pathway. The present study further evaluated the effect of RSV and E2 in the anti-apoptosis process of IVDD.
METHODS: Human nucleus pulposus (NP) cells culture system and IL-1β inducing apoptosis model were constructed in this research. RSV and E2 were used to inhibit apoptosis. FACS (Fluorescence-activated cell sorting) and CCK-8 (Cell Counting Kit-8) assays were respectively used to determine apoptotic incidence and cell viability of NP cells. Quantitative RT-PCR was used to determine expression of target genes in mRNA level, and western blot analysis was performed to detect the changes of related protein expression.
RESULTS: RSV combined with E2 attenuated IL-1β-induced cell apoptosis and recovered cell viability. Blockers for mTOR and GSK-3β abated the effect of RSV and E2. RSV combined with E2 obviously increased activated P-mTOR and P-GSK-3β, which contributes to the downregulation of caspase-3. Activated P-NF-kappa B was not involved in the anti-apoptosis process of RSV and E2.
CONCLUSION: Combination of Resveratrol and 17β-estradiol efficiently resisted IL-1β induced apoptosis of NP cell, mainly through PI3K/AKT/mTOR/caspase-3 and PI3K/AKT/GSK-3β pathway.

Entities:  

Keywords:  17β-estradiol; Nucleus pulposus (NP); intervertebral disc degeneration (IVDD); resveratrol

Mesh:

Substances:

Year:  2020        PMID: 32036721     DOI: 10.1080/08941939.2019.1705941

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  6 in total

Review 1.  Recent Advances in Managing Spinal Intervertebral Discs Degeneration.

Authors:  Bogdan Costăchescu; Adelina-Gabriela Niculescu; Raluca Ioana Teleanu; Bogdan Florin Iliescu; Marius Rădulescu; Alexandru Mihai Grumezescu; Marius Gabriel Dabija
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

2.  Correlation Analysis between Tamoxifen and Lumbar Intervertebral Disc Degeneration: A Retrospective Case-Control Study.

Authors:  Xiangyu Li; Ruoyu Zhao; Samuel Rudd; Wenyuan Ding; Sidong Yang
Journal:  Pain Res Manag       Date:  2022-05-31       Impact factor: 2.667

Review 3.  Genetic Therapy for Intervertebral Disc Degeneration.

Authors:  Eun Ji Roh; Anjani Darai; Jae Won Kyung; Hyemin Choi; Su Yeon Kwon; Basanta Bhujel; Kyoung Tae Kim; Inbo Han
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 4.  The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.

Authors:  Mohammad Rafi Khezri; Reza Varzandeh; Morteza Ghasemnejad-Berenji
Journal:  Cell Mol Biol Lett       Date:  2022-01-11       Impact factor: 5.787

5.  Programmed NP Cell Death Induced by Mitochondrial ROS in a One-Strike Loading Disc Degeneration Organ Culture Model.

Authors:  Bao-Liang Li; Xizhe Liu; Manman Gao; Fu Zhang; Xu Chen; Zhongyuan He; Jianmin Wang; Wei Tian; Dafu Chen; Zhiyu Zhou; Shaoyu Liu
Journal:  Oxid Med Cell Longev       Date:  2021-08-31       Impact factor: 6.543

Review 6.  Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway.

Authors:  Soudeh Ghafouri-Fard; Zahra Bahroudi; Hamed Shoorei; Bashdar Mahmud Hussen; Seyedeh Fahimeh Talebi; Sadia Ghousia Baig; Mohammad Taheri; Seyed Abdulmajid Ayatollahi
Journal:  Cancer Cell Int       Date:  2022-09-30       Impact factor: 6.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.